148 related articles for article (PubMed ID: 26830359)
1. High Throughput Screening for Colorectal Cancer Specific Compounds.
Xie J; Wang C; Gore JC
Comb Chem High Throughput Screen; 2016; 19(3):180-8. PubMed ID: 26830359
[TBL] [Abstract][Full Text] [Related]
2. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
Griffiths M; Sundaram H
Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
[TBL] [Abstract][Full Text] [Related]
3. New naphthoquinone derivatives against glioma cells.
Redaelli M; Mucignat-Caretta C; Isse AA; Gennaro A; Pezzani R; Pasquale R; Pavan V; Crisma M; Ribaudo G; Zagotto G
Eur J Med Chem; 2015; 96():458-66. PubMed ID: 25916907
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.
Langenhan JM; Peters NR; Guzei IA; Hoffmann FM; Thorson JS
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12305-10. PubMed ID: 16105948
[TBL] [Abstract][Full Text] [Related]
5. Isocostunolide inhibited glioma stem cell by suppression proliferation and inducing caspase dependent apoptosis.
Dai Z; Li SR; Zhu PF; Liu L; Wang B; Liu YP; Luo XD; Zhao XD
Bioorg Med Chem Lett; 2017 Jul; 27(13):2863-2867. PubMed ID: 28487072
[TBL] [Abstract][Full Text] [Related]
6. Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells.
Teixeira RG; Brás AR; Côrte-Real L; Tatikonda R; Sanches A; Robalo MP; Avecilla F; Moreira T; Garcia MH; Haukka M; Preto A; Valente A
Eur J Med Chem; 2018 Jan; 143():503-514. PubMed ID: 29202411
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of glycoside inhibitors of glioma and melanoma growth.
García-Alvarez I; Corrales G; Doncel-Pérez E; Muñoz A; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2007 Jan; 50(2):364-73. PubMed ID: 17228879
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
Shi LS; Kuo SC; Sun HD; Morris-Natschke SL; Lee KH; Wu TS
Bioorg Med Chem; 2014 Mar; 22(6):1889-98. PubMed ID: 24582402
[TBL] [Abstract][Full Text] [Related]
10. The isoprenoid derivative N
Ciaglia E; Grimaldi M; Abate M; Scrima M; Rodriquez M; Laezza C; Ranieri R; Pisanti S; Ciuffreda P; Manera C; Gazzerro P; D'Ursi AM; Bifulco M
Br J Pharmacol; 2017 Jul; 174(14):2287-2301. PubMed ID: 28419419
[TBL] [Abstract][Full Text] [Related]
11. The Potential Targets and Mechanisms of a Carbazole and Pyrazole Containing Anticancer Compound.
Xie J; Gore JC
Curr Cancer Drug Targets; 2020; 20(5):364-371. PubMed ID: 31951182
[TBL] [Abstract][Full Text] [Related]
12. Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability.
Braga C; Vaz AR; Oliveira MC; Matilde Marques M; Moreira R; Brites D; Perry MJ
Eur J Med Chem; 2019 Jun; 172():16-25. PubMed ID: 30939350
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3-triazoles and their evaluation as potential anticancer agents.
Allam M; Bhavani AKD; Mudiraj A; Ranjan N; Thippana M; Babu PP
Eur J Med Chem; 2018 Aug; 156():43-52. PubMed ID: 30006173
[TBL] [Abstract][Full Text] [Related]
14. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
15. Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).
Nakase I; Katayama M; Hattori Y; Ishimura M; Inaura S; Fujiwara D; Takatani-Nakase T; Fujii I; Futaki S; Kirihata M
Chem Commun (Camb); 2019 Nov; 55(93):13955-13958. PubMed ID: 31617510
[TBL] [Abstract][Full Text] [Related]
16. Natural Hypoxia is Not a Limiting Factor in Evaluating the Novel Arylidene Derivative MLT-401 Against an In Vitro Colorectal Cancer Model.
Bin-Jaliah I
Cell Physiol Biochem; 2018; 46(5):2082-2089. PubMed ID: 29723868
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of neurostatin-related compounds with high inhibitory activity of glioma growth.
Valle-Argos B; Gómez-Nicola D; Nieto-Sampedro M
Eur J Med Chem; 2010 May; 45(5):2034-43. PubMed ID: 20153569
[TBL] [Abstract][Full Text] [Related]
18. N-Aryl-N'-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis.
Goffin E; Lamoral-Theys D; Tajeddine N; de Tullio P; Mondin L; Lefranc F; Gailly P; Rogister B; Kiss R; Pirotte B
Eur J Med Chem; 2012 Aug; 54():834-44. PubMed ID: 22809560
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the metastatic progression of breast and colorectal cancer in vitro and in vivo in murine model by the oxidovanadium(IV) complex with luteolin.
Naso LG; Badiola I; Marquez Clavijo J; Valcarcel M; Salado C; Ferrer EG; Williams PAM
Bioorg Med Chem; 2016 Nov; 24(22):6004-6011. PubMed ID: 27707626
[TBL] [Abstract][Full Text] [Related]
20. Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.
Paterni I; Bertini S; Granchi C; Tuccinardi T; Macchia M; Martinelli A; Caligiuri I; Toffoli G; Rizzolio F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Minutolo F
J Med Chem; 2015 Feb; 58(3):1184-94. PubMed ID: 25559213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
